Encap Drug Delivery

  • Offers preformulation and formulation services; expertise in lipid films/ lipid formulations
  • Able to enhance bioavailability of poorly soluble drugs, formulate hygroscopic and oxidation-sensitive compounds; potent drugs; immediate, controlled, and sustained release; low-melting-point compounds; biolo...
  • This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

    Related Research

    Google-backed Calico and AbbVie announce second extension of a long-standing partnership to tackle aging-related diseases

    News Commentary | July 30, 2021

    Google‑backed Calico and pharma giant AbbVie are doubling down on tackling aging‑related diseases with this second partnership extension. Twenty early‑stage programs have been developed across oncology and neurodegeneration, with the lead oncology target, which acts at multiple steps in the cancer ... Not part of subscription

    Genevant enters partnership with Takeda for developing rare liver disease therapies

    News Commentary | September 08, 2021

    Genevant Sciences develops lipid nanoparticle (LNP) nucleic acid delivery techniques, which can be utilized for mRNA‑based applications including vaccines, protein production, and nonviral gene therapies. The two companies reached an agreement for Genevant to develop therapeutics for two undisclosed... Not part of subscription

    Regulus Therapeutics

    Company Profile | December 01, 2021

    Regulus Therapeutics was created as a joint venture between Alnylam Pharmaceuticals, an RNAi therapeutics company, and Isis Pharmaceuticals (now known as Ionis Pharmaceuticals), a company focused on anti‑sense technologies and therapeutics, in 2007 Regulus Therapeutics is focused on the ... Not part of subscription